Jci_page_head_homepage_01 Jci_page_head_homepage_02
Jake A. Kushner, Jing Ye, Markus Schubert, Deborah J. Burks, Matthew A. Dow, Carrie L. Flint, Sanjoy Dutta, Christopher V.E. Wright, Marc R. Montminy, Morris F. White
Published in Volume 109, Issue 9
J Clin Invest. 2002; 109(9):1193–1201 doi:10.1172/JCI14439
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Characterization of male progeny of Irs2+/–Pdx1tg intercross. (a and b) Random-fed blood glucose (a) and serum insulin (b) of Irs2+/–Pdx1tg intercross mice at 4–5 weeks, 12–13 weeks, and 12–16 months. Results are mean ± SEM of six mice per genotype. *P < 0.05, Irs2–/– vs. wild-type; **P < 0.01, Irs2–/– vs. wild-type; #P < 0.05, Irs2–/–Pdx1tg vs. Irs2–/–; ##P < 0.01, Irs2–/–Pdx1tg vs. Irs2–/–. (c) Insulin tolerance test of 4- to 5-week-old fed mice performed with 0.75 U/kg human regular insulin on fed animals. Results are expressed as mean ± SEM of percent of initial blood glucose value for at least eight animals per genotype. *P < 0.05 and **P < 0.01 vs. wild-type. (d) Glucose tolerance tests of 12- to 13-week-old mice performed with 2 g D-glucose per kg body weight after a 15- to 16-hour fast. Results reported as mean ± SEM for at least eight animals per genotype. *P < 0.05 vs. wild-type; **P < 0.01 vs. wild-type; ##P < 0.01, Irs2–/–Pdx1tg vs. Irs2–/–.